SBIR/STTR Research Award
Reagents for Immunologic Analysis of Under-represented Mammalian Models
Award amount
$600,000Program and phase
SBIR · Phase IAward year
2023Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- INTEGRAL MOLECULAR INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- DY9KSWE8EJB8
- Solicitation number
- PHS-2023-1
- Topic code
- 118
Research abstract
Integral Molecular proposes to generate a large panel of pan-reactive monoclonal antibodies (mAbs) against immune cell markers to be used instudies of immune function and responses in nine underrepresented mammalian models. Since certain mammalian models display many features of human immunity but are similarly underutilized due to lack of immunologic reagents, development of cross-reacting antibodies to study immune responses in several animal species will impact the understanding of several human diseases.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- ANTIBODY REAGENTS FOR IMMUNOLOGIC ANALYSIS OF UNDER-REPRESENTED MAMMALIAN MODELS
- High-throughput Discovery of Antibodies against Understudied Membrane Proteins using mRNA
- Specificity Screening Drug Development Tool for Biotherapeutic Safety
- Development of Safe and Rapid Reporter Viruses for Studying Pathogenic and Pandemic Viruses
- High-throughput Discovery of Antibodies against Understudied Membrane Proteins
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Affinity Reagents for the Immune System of Golden Hamster (for SARS-CoV-2 induced long-COVID disease)
- Development of Monoclonal Antibodies for the Study of Mycobacterium tuberculosis (Mtb) in the Guinea Pig
- Epitope-directed monoclonal antibody production for mosquito immune cells (for malaria)
- EAP-Derived Monoclonal Antibodies for Phenotyping Immune Cells of Animal Model of Disease
Research funding history
48 SBIR/STTR records share this UEI (2002–2025). Reported award amounts total $32,839,788. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services